Cabanlit, Remelda B.

HRN: 23-99-29  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2025
CEFUROXIME 500MG (TAB)
08/09/2025
08/16/2025
PO
500MG
BID
TMSAF
Remove - Pending Acceptance
08/09/2025
METRONIDAZOLE 500MG (TAB)
08/09/2025
08/16/2025
PO
500MG
TID
TMSAF
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: